kidney disease RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia. Renalytix AI Lands US Government Contract for Kidney Disease Test The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates. NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise. NephroSant Raises $16M in Series A Funding Round The startup will use the funds to support R&D and to launch its Qsant urine test to help determine if a patient's body is rejecting a kidney transplant. Feb 24, 2021 RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health Jan 22, 2021 Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease Premium Jan 19, 2021 Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores Dec 2, 2020 Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment Nov 3, 2020 Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection Premium Aug 21, 2020 RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes Jun 30, 2020 RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm Jun 12, 2020 RenalytixAI Receives Approval From New York State to Offer Kidney Test Apr 28, 2020 RenalytixAI, Mount Sinai Launch Study to Predict COVID-19 Kidney Complications Premium Mar 18, 2020 Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay Premium Mar 17, 2020 Viracor Eurofins, National Kidney Registry Partner to Provide SARS-CoV-2 Testing Feb 18, 2020 Natera Countersues CareDx for False Advertising Jan 21, 2020 Urinary Metabolite GWAS Leads to Risk Variants, Potential Markers of Kidney Disease Jan 8, 2020 Magistrate Judge Recommends Partial Rejection of Natera Motion to Dismiss CareDx False Advertising Lawsuit Dec 19, 2019 Natera Obtains Final Medicare Local Coverage Determination for Kidney Transplant Test From Palmetto Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Oct 31, 2019 CareDx Q3 Revenues Up 60 Percent Oct 2, 2019 Liquid Biopsy Test Targets Early Detection of Diabetes Complications, Cancers Premium Sep 26, 2019 Human Kidney Immune Cell Map Reveals Multiple Infection Protection Zones Sep 20, 2019 GWAS in Diabetes Patients Uncovers Risk Loci for Kidney Disease Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.